S. 2236 - Advancing Breakthrough Therapies for Patients Act of 2012
- Sponsor:
- Michael F. Bennet
- Summary:
- A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs. (by CRS)
- Status:
- The bill has been introduced.
Advancing Breakthrough Therapies for Patients Act of 2012
S. 2236 — 112th Congress (2011–2012)
- Summary
- A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs.
- Other Titles
- Advancing Breakthrough Therapies for Patients Act of 2012
- Sponsor
- Michael F. Bennet
- Co-Sponsors
- Subjects
- Health
- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Related Bills
- Major Actions
Introduced 3/26/2012 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/26/2012 3/26/2012 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
Contributions data source: OpenSecrets.org